---
document_datetime: 2023-09-21 20:37:01
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lenalidomide-krka-dd-novo-mesto-epar-all-authorised-presentations_en.pdf
document_name: lenalidomide-krka-dd-novo-mesto-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8871083
conversion_datetime: 2025-12-24 14:22:55.939023
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name                   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging            | Pack size                  |
|------------------|-----------------------------------|------------|-----------------------|---------------------------|--------------------------------|----------------------------|
| EU/1/20/1520/001 | Lenalidomide Krka d.d. Novo mesto | 2.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1520/002 | Lenalidomide Krka d.d. Novo mesto | 2.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x 1 capsule (unit dose) |
| EU/1/20/1520/003 | Lenalidomide Krka d.d. Novo mesto | 5 mg       | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1520/004 | Lenalidomide Krka d.d. Novo mesto | 5 mg       | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x 1 capsule (unit dose) |
| EU/1/20/1520/005 | Lenalidomide Krka d.d. Novo mesto | 7.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1520/006 | Lenalidomide Krka d.d. Novo mesto | 7.5 mg     | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x 1 capsule (unit dose) |
| EU/1/20/1520/007 | Lenalidomide Krka d.d. Novo mesto | 10 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1520/008 | Lenalidomide Krka d.d. Novo       | 10 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x 1 capsule (unit dose) |
| EU/1/20/1520/009 | Lenalidomide Krka d.d. Novo mesto | 15 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1520/010 | Lenalidomide Krka d.d. Novo mesto | 15 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x1 capsule (unit dose)  |
| EU/1/20/1520/011 | Lenalidomide Krka d.d. Novo mesto | 20 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |
| EU/1/20/1520/012 | Lenalidomide Krka d.d. Novo mesto | 20 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x 1 capsule (unit dose) |
| EU/1/20/1520/013 | Lenalidomide Krka d.d. Novo mesto | 25 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 7 x 1 capsule (unit dose)  |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name                   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging            | Pack size                  |
|------------------|-----------------------------------|------------|-----------------------|---------------------------|--------------------------------|----------------------------|
| EU/1/20/1520/014 | Lenalidomide Krka d.d. Novo mesto | 25 mg      | Capsule, hard         | Oral use                  | blister (OPA/Alu/PVC- PET/Alu) | 21 x 1 capsule (unit dose) |